1-8 of 8
Edit anna Porpaczy
Close
Sort by
Journal Articles

Treatment Guided By Next Generation Functional Drug Screening Provides Clinical Benefit in Advanced Aggressive Hematological Malignancies: Final Evaluation of the Open Label, Single Arm Exalt Trial

Christoph Kornauth, Tea Pemovska, PhDMSc,BSc, Gregory Ian Vladimer, PhD, Günther Bayer, Michael Bergmann, Sandra Eder, Ruth Eichner, Harald Esterbauer, MD PhD, Ruth Exner, Verena Felsleitner-Hauer, Maurizio Forte, MSc, Alexander Gaiger, Hildegard T. Greinix, MD, Wolfgang Gstöttner, Marcus Hacker, Alexander Hauswirth, MD, Tim Heinemann, Daniel Heintel, Mir Ali Reza Hoda, Ulrich Jaeger, Lukas Kazianka, MD, Lukas Kenner, MD, Barbara Kiesewetter, MD, Nikolaus Krall, PhD, Trang Le, BSc, Simone Lubowitzki, Marius E Mayerhoefer, Elisabeth Menschel, Olaf Merkel, PhD, Katsuhiro Miura, MD PhD, Leonhard Muellauer, MD PhD, Peter Neumeister, MD, Thomas Noesslinger, MD, Katharina Ocko, Leopold Öhler, Michael Panny, MD, Alexander Pichler, MD, Edit Anna Porpaczy, MD, Gerald Prager, MD, Markus Raderer, Robin Ristl, Reinhard Ruckser, MD, Julius Salamon, Ana-Iris Schiefer, Ann-Sofie Schmolke, MD, Ilse Schwarzinger, MD, Edgar Selzer, Cathrin Skrabs, Wolfgang R. Sperr, MD, Ismet Srndic, MSc, Renate Thalhammer, MD, Peter Valent, MD, Emiel van der Kouwe, PharmD, Katrina Vanura, PhD, Stefan Vogt, Cora Waldstein, Dominik Wolf, Univ. Prof. Dr., Christoph Zielinski, Ingrid Simonitsch-Klupp, MD, Giulio Superti-Furga, PhD, Berend Snijder, PhD, Philipp B. Staber, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–4.
https://doi.org/10.1182/blood-2020-140831
Published: 2020
Journal Articles

JAK2-Inhibitor Therapy Associated Lymphomas in Myelofibrosis: Distinct Clinico-Pathological Features Recapitulated in a Mouse Model

Sabrina Tripolt, PhD, Edit Anna Porpaczy, MD, Andrea Hoelbl-Kovacic, PhD, Bettina Gisslinger, Zsuzanna Bago-Horvath, PhD, Emilio Casanova, PhD, Thomas Decker, PhD, Daniela Fux, PhD, Gerwin Heller, MD, Harald Herkner, MD, Thomas Kolbe, PhD, Christoph Kornauth, MD, Mathias Mueller, PhD, Michaela Prchal-Murphy, PhD, Ana Iris Schiefer, MD, Christine Schneckenleithner, PhD, Cathrin Skrabs, MD, Wolfgang R. Sperr, MD, Philipp Bernhard Staber, MD PhD, Birgit Strobl, PhD, Peter Valent, MD, Ingrid Simonitsch-Klupp, MD, Gregor Hoermann, MD, Jean-Jacques Kiladjian, MD PhD, Robert Kralovics, PhD, Maria-Theresa Krauth, MD, Ulrich Jaeger, MD, Veronika Sexl, MD PhD, Heinz Gisslinger
Journal: Blood
Blood (2017) 130 (Supplement 1): 1643.
https://doi.org/10.1182/blood.V130.Suppl_1.1643.1643
Published: 2017
Journal Articles

Integrated ATAC-Seq and Chemosensitivity Profiling Identifies Rational Drug Combinations in Ibrutinib-Treated CLL Patients

Gregory Ian Vladimer, PhD, Christian Schmidl, PhD, Andre Renderio, MS, Susanne Schnabl, MS, Tea Pemovska, PhD, Berend Snijder, PhD, Thomas Krausgruber, PhD, Nikolaus Krall, PhD, Mohammad Araghi, Rainer Hubmann, Anna Ringler, Dita Demirtas, Oscar Lopez de la Fuente, BSc, Martin Hilgrath, Cathrin Skrabs, MD, Edit Anna Porpaczy, MD, Michaela Gruber, MD PhD, Gregor Hoermann, MD, Stefan Kubicek, PhD, Philipp Bernhard Staber, MD PhD, Medhat M. Shehata, MD, Giulio Superti-Furga, PhD, Christoph Bock, PhD, Ulrich Jaeger, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 800.
https://doi.org/10.1182/blood.V130.Suppl_1.800.800
Published: 2017
Journal Articles

Ristocetin-Induced Platelet Aggregation for Monitoring of Bleeding Tendency in Ibrutinib-Treated Patients with Chronic Lymphocytic Leukemia

Lukas Kazianka, Christa Drucker, Cathrin Skrabs, MD, Philipp Bernhard Staber, MD PhD, Edit Anna Porpaczy, MD PhD, Christine Einberger, Marion Heinz, Alexander Hauswirth, MD, Ingrid Pabinger, MD, Peter Quehenberger, MD, Bernd Jilma, MD, Ulrich Jaeger, MD
Journal: Blood
Blood (2015) 126 (23): 718.
https://doi.org/10.1182/blood.V126.23.718.718
Published: 2015
Journal Articles

A New Prognostic Score for Aggressive B-Cell Lymphoma with C-MYC Translocation Integrating Clinical and Genetic Features.

Ana-Iris Schiefer, Michael Melcher, Zsuzsanna Bago-Horvath, Sandra Eder, Cathrin Skrabs, Alexander Hauswirth, Berthold Streubel, M.D., Christine Mannhalter, Dagmar Stoiber, Veronika Sexl, MD, Leonhard Müllauer, Ulrich Jaeger, MD, Edit Anna Porpaczy, MD
Journal: Blood
Blood (2012) 120 (21): 2685.
https://doi.org/10.1182/blood.V120.21.2685.2685
Published: 2012
Journal Articles

Cannabinoid Receptor 1 in Chronic Lymphocytic Leukemia: Strong Prognostic Marker with Limited Therapeutic Use

Patricia Weiss, Edit Anna Porpaczy, MD, Trang Le, Cathrin Skrabs, Michaela Gruber, Clemens Pausz, Ulrich Jäger, Katrina Vanura
Journal: Blood
Blood (2012) 120 (21): 4565.
https://doi.org/10.1182/blood.V120.21.4565.4565
Published: 2012
Journal Articles

Expression of Lipoprotein Lipase In Chronic Lymphocytic Leukemia Cells: Is There a Biological Function?

Edit anna Porpaczy, MD, Stefanie Tauber, Martin Bilban, Gerhard Kostner, Michaela Gruber, Trang Le, Karin Fleiss, Cathrine Skrabs, Christine Einberger, Medhat Shehata, Ulrich Jaeger, Katrina Vanura
Journal: Blood
Blood (2010) 116 (21): 3580.
https://doi.org/10.1182/blood.V116.21.3580.3580
Published: 2010
Journal Articles

Identification of Genes Associated with Resistance and Response in Vivo to Therapy with Rituximab, Fludarabine and Cyclophosphamide in Patients with Chronic Lymphocytic Leukemia.

Medhat Shehata, MD, Dita Demirtas, MD, Stefanie Tauber, MD, Susanne Schnabl, Martin Bilban, PhD, Martin Hilgarth, Oswald Wagner, MD, Christa Fonatsch, MD, Ilse Schwarzinger, MD, Georg Hopfinger, MD, Karin Eigenberger, MD, Cathrin Skrabs, MD, Daniel Heintel, MD, Edit Anna Porpaczy, MD, Katrina Vanura, PhD, Stephan Stilgenbauer, MD, PhD, Michael Hallek, MD, Josef D. Schwarzmeier, MD, Rainer Hubmann, PhD, Alexander Gaiger, MD, Ulrich Jaeger, MD
Journal: Blood
Blood (2008) 112 (11): 1622.
https://doi.org/10.1182/blood.V112.11.1622.1622
Published: 2008